UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2022 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
UNBX
Shares outstanding
17,209,280
Price per share
$0.08
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-26,963
Value change
-$1,675
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Alyeska Investment Group, L.P. 9.2% $1,546,529 1,578,091 Alyeska Investment Group, L.P. 31 Mar 2025

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX). This represents 0% of the company’s total 17,209,280 outstanding shares.

Institutional Holders of UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$1,675 $0.08 0
2025 Q3 27,018 $1,678 -$981,494 $0.06 5
2025 Q2 2,582,539 $987,264 -$333,569 $0.38 34
2025 Q1 2,833,599 $2,947,154 -$356,278 $1.04 38
2024 Q4 3,178,598 $3,103,762 -$259,368 $0.98 35
2024 Q3 3,460,556 $5,086,884 +$29,141 $1.47 37
2024 Q2 3,450,626 $4,657,886 -$194,257 $1.35 38
2024 Q1 3,582,663 $5,874,222 -$1,430,936 $1.64 39
2023 Q4 4,316,069 $8,330,359 +$3,170,392 $1.93 41
2023 Q3 2,675,121 $6,420,387 -$56,636 $2.40 36
2023 Q2 2,694,748 $6,871,402 -$979,883 $2.55 38
2023 Q1 3,151,722 $5,134,660 -$2,785,787 $1.63 43
2022 Q4 4,394,642 $152,591,456 +$124,781,330 $2.74 49
2022 Q3 10,458,677 $4,135,114 +$4,135,114 $0.40 3